Close Menu

NEW YORK (GenomeWeb) - Biocept reported today after the close of the market that its first quarter revenues rose to $150,000 compared to $28,000 in Q1 2014, with the increase primarily due to growing commercial liquid biopsy test volumes.

The San Diego-based firm, which sells molecular diagnostic tests based on circulating tumor cells and circulating tumor DNA, said it tested 247 commercial cases during the first quarter of 2015, up from 11 commercial cases during the first quarter of 2014.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.